Ashutosh Chilkoti information

Ashutosh Chilkoti is an Indian American biomedical engineer, academic, researcher and serial entrepreneur. He is the Alan L. Kaganov Professor of Biomedical Engineering and Senior Associate Dean in the Pratt School of Engineering at Duke University.^[1]

Chilkoti has published over 350 papers, has been cited 48,000 times, has a Google Scholar H-index of 116 and has 62 US patents awarded. His research is focused on genetically encoded materials and biointerface science and he has pioneered the development of high-throughput and scalable methods for the recombinant synthesis of repetitive polypeptides, invented a method to purify protein drugs without chromatography, and developed a technology for point-of-care clinical diagnostics. He has founded five start-up companies, including PhaseBio Pharmaceuticals in 2002, Sentilus in 2011, Gateway Bio in 2017, Isolere Bio in 2018, and inSoma Bio in 2019.^[2]

Chilkoti is a Fellow of American Association for the Advancement of Science,^[3] National Academy of Inventors,^[4] Biomedical Engineering Society,^[5] Controlled Release Society,^[6] International Union of Societies for Biomaterials Science and Engineering and American Institute for Medical and Biological Engineering (AIMBE).^[7]